1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Pharmarise Holdings Corporation

Pharmarise Holdings Corporation

2796.T
Pharmarise Holdings CorporationJP flagTokyo Stock Exchange
484.00
JPY
- -
- -
5.57BMarket Cap
Pharmarise Holdings Corporation
2796.T
(Tokyo Stock Exchange)

Recent

price

484.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
4,230.14
3,947.45
4,447.43
4,820.35
4,388.02
5,386.58
5,863.21
6,036.25
5,655.81
5,397.82
5,622.95
5,530.61
5,534.76
5,184.36
5,609.47
- -
5,778.55
Revenue per Share
88.78
91.44
127.73
46.55
25.31
42.42
0.78
-3.1
2.51
61.03
45.78
47.9
35.42
-33.41
-32.42
- -
-37.24
Basic EPS, GAAP
90.89
229.29
64.37
53.1
307.89
-92.72
169.09
102.33
47.78
117.94
149.7
26.47
210.41
199.41
53.79
- -
- -
Free Cash Flow per Basic Share
6.4
8.67
10
13.24
13.99
15.88
13.84
13.94
13.67
13.65
13.86
14.04
13.94
12.09
19.79
- -
- -
Dividend per Share
331.36
362.93
480.66
532.05
484.05
476.58
333.09
445.4
434.94
468.17
509.92
544.94
565.07
522.66
432.71
- -
582.57
Book Value per Share
123.03
94.89
-378.47
-199.44
-109.33
-20.1
-29.79
-2.1
48
69.6
200.74
329
397.53
97.37
-30.91
- -
108.53
Tangible Book Value per Share
6
8
8
8
9
9
9
9
9
9
9
9
9
11
11
- -
9
Basic Weighted Avg Shares
26,825
29,607
33,357
38,221
39,506
48,511
52,949
54,562
51,728
51,030
52,324
51,608
52,030
54,466
63,508
- -
54,466
Sales/Revenue/Turnover
5.58
5.6
4.23
4.11
2.89
1.68
0.84
2.16
1.24
2.03
2.38
2.95
2.77
1.68
0.46
- -
1.68
Operating Margin (%)
603
672
836
1,082
1,158
1,198
1,293
1,326
1,223
1,228
1,344
1,308
1,224
1,170
1,493
- -
- -
Depreciation Expense
563
686
958
369
228
382
7
-28
23
577
426
447
333
-351
-367
- -
-351
Net Income, GAAP
51.08
51.53
40.89
67.37
75.78
63.96
25,100
150.24
102.25
29.06
65.06
65.28
66.92
340.56
4,887.5
- -
340.56
Effective Tax Rate (%)
2.1
2.32
2.87
0.97
0.58
0.79
0.01
-0.05
0.04
1.13
0.81
0.87
0.64
-0.64
-0.58
- -
-0.64
Profit Margin (%)
103
153
-3,110
-1,555
-2,367
-1,665
-1,440
-1,827
254
640
1,154
2,401
1,537
3,049
1,251
- -
3,049
Working Capital
4,389
4,991
7,229
8,433
7,157
7,832
7,924
6,947
8,195
8,133
7,878
7,422
5,461
9,918
11,482
- -
9,918
LT Debt
2,919
3,563
4,459
5,629
5,811
6,237
5,900
5,622
5,614
5,942
6,331
6,698
6,986
7,440
6,916
- -
7,440
Total Equity
7.68
7.41
5.89
2.94
1.62
1.73
-635.69
-3.52
-0.09
4.27
2.48
3.05
2.84
-11.93
-67.1
- -
-11.93
Return on Invested Capital (%)
7.21
7.59
8.06
2.66
1.74
2.91
-204.77
0.67
0.36
4.05
2.93
3
2.28
-3.16
-47.28
- -
-3.16
Return on Capital (%)
32.69
28.44
30.28
9.44
5.31
8.83
0.19
-0.8
0.57
13.73
9.29
9.09
6.41
-6.5
-7.06
- -
-6.5
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Nov'24
Feb'24
May'24
ST Debt
1,738
2,263
2,831
LT Borrowings
4,905
8,300
9,654
LT Finance Leases
- -
- -
264
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
11
11
Market Capitalization
6,032
6,155
6,079

Working Capital

FRC

•

in mil. unless spec.
Nov'24
Feb'24
May'24
Total Current Assets
10,875
11,761
13,737
Cash, Cash Equivalents & STI
4,923
5,164
7,153
Accounts Receivable, Net
632
642
1,442
Inventories
2,494
3,329
2,645
Total Current Liabilities
8,241
8,724
10,688
Payables & Accruals
- -
- -
- -
ST Debt
1,738
2,263
2,831
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13,471
13,477
13,726
13,792
54,466
2025
- -
- -
- -
- -
63,508
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13.05
- -
- -
- -
-33.41
2025
- -
- -
- -
- -
-32.42
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
12.09
2025
- -
- -
- -
- -
19.79
2026
- -
- -
- -
- -
- -
Similar Companies
AFT Corporation Limited (AFT.AX)
Rimrock Gold Corp. (RMRK)
Welcure Drugs & Pharmaceuticals Limited (WELCURE.BO)
AstraZeneca PLC ADRhedged (AZNH)
Advantis Corp. (ADVT)
Transchem Limited (TRANSCHEM.BO)
Business
Pharmarise Holdings Corporation Pharmarise Holdings Corporation (2796.T) serves as a Japan-based holding company primarily engaged in the management and operation of dispensing pharmacies, drug stores, and convenience stores across Japan. The company offers core services including prescription dispensing based on medical institution prescriptions; operation of drug and convenience stores with sales of cosmetics and over-the-counter products; storage and management of patient medical examination records on behalf of medical institutions; operation of medical malls; provision of system integration services and medical IT solutions to pharmaceutical companies; and temporary help and employment placement services. Established in June 1984 and headquartered at 1-38-1 Chuo, Nakano-ku, Tokyo, Japan, Pharmarise Holdings operates approximately 399 stores as of June 2024, with 1,869 consolidated employees as of May 2022, primarily targeting community healthcare needs in an aging Japanese population through its core dispensing pharmacy segment, which accounts for over 80% of net sales. Recent major developments include the acquisition of the GOOD AID Group, adding 38 stores, completed in January 2024; the acquisition of the Nagisa Group, incorporating 54 stores, finalized in December 2024; and a capital and business alliance with Suzuken Corporation, where Suzuken increased its stake to 20% by January 2024 to enhance collaboration in pharmacy operations and digital transformation initiatives. These expansions, alongside investments in family pharmacist guidance fees, community support system premiums, and dispensing at elderly care facilities, position the company for industry consolidation amid dispensing fee revisions and national health insurance adjustments, while its medium-term management plan targets sustainable growth through enhanced operational efficiency and store network expansion.